A Pill for Ebola? New Drug Shows Up to 100% Survival in Monkeys
New research this month shows that the experimental antiviral obeldesivir prevented up to 100% of deaths in monkeys infected ...
Paxlovid may not reduce hospitalization risk for vaccinated older adults
A new study suggests Paxlovid may not reduce the risk of covid-19 hospitalizations and all-cause deaths in vaccinated adults ...
C&EN7d
Pfizer readies its next-generation COVID-19 antiviral
An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...
Sacramento Bee7d
NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company
SHELTON, CT / ACCESS Newswire / March 11, 2025 / NanoViricides, Inc. (the "Company")(NYSE American:NNVC), a clinical-stage global leader developing revolutionary broad-spectrum antiviral drugs that ...